Affinity, JSW partnership expands reach & services

By Nick Taylor

- Last updated on GMT

Affinity Life Sciences and JSW Life Sciences have entered into a strategic partnership to bolster their contract research and manufacturing capabilities.

Partnering expands the range of services JSW and Affinity can offer to clients. Furthermore, the alliance represents a geographic expansion as JSW is based in Austria and Affinity’s headquarters is in Milford, New Hampshire, US.

JSW also has an office in Zagreb, Croatia. From this location JSW supports clinical trials in Eastern Europe, notably in Croatia, Slovenia, Bosnia and Herzegovina, Serbia and Macedonia.

Commenting on the geographic expansion, Manfred Windisch, president of JSW, said the deal allows the company “to further serve our North American and European clients​”.

Windisch added that partnering will provide JSW’s clients “with additional biomarker assay development and good manufacturing practice (GMP) production services in support of drug development​”.

Furthermore, Affinity, a contract manufacturing organisation (CMO), will provide JSW’s clients with immunoassay design, cell culture services and antibody purification and conjugation services.

In return Affinity’s clients will have access to a range of in vitro ​and in vivo ​services, including transgenic mouse models, offered by JSW, a neuroscience contract research organisation (CRO).

The deal with Affinity is the third partnership JSW has entered into. Through an alliance with HM Pharma Consultancy, which has offices in Vienna, Austria and Salt Lake City, Utah, US, it can offer clients assistance with patenting and intellectual property management.

JSW also has an established relationship with vuGene, a company offering direct to consumer genetic testing for mental and neurological conditions.

Related news

Show more

Related products

show more

The APAC Advantages

The APAC Advantages

Catalent Pharma Solutions | 18-Jan-2022 | Insight Guide

Over recent years, the Asia-Pacific (APAC) region has become an emerging market for pharmaceutical and biotech innovation, including clinical studies.

CellCarta - Mapping Precision Medicine

CellCarta - Mapping Precision Medicine

CellCarta | 17-Jan-2022 | Product Presentation

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

Planning Your Preclinical Assessment

Planning Your Preclinical Assessment

Altasciences | 17-Jan-2022 | Technical / White Paper

There are many challenges associated with early drug discovery and development. Advancing your best candidate for regulatory submissions requires a careful...

How a Clinical MDR Helps with Data Quality

How a Clinical MDR Helps with Data Quality

Formedix | 17-Jan-2022 | Technical / White Paper

This article covers the many ways a clinical metadata repository helps with data quality in the clinical trial process, and how it ultimately helps to...

Related suppliers

Follow us


View more